Solution
Device Design Optimization
In-silico experiments provide valuable insight into the effectiveness of new ICD designs. Integrating simulation early in the design and development process greatly improves efficiency and time-to-market, while reducing risk to patients by providing a realistic virtual test environment.
Challenges
Cardiac device design and development faces many challenges that are costly to overcome with only real-world experimentation and testing:
Many options need to be evaluated, including device location, field vector and material properties.
Development cycles are expensive, alternating between device design and lab testing.
Real-world experiments do not allow for precise sensitivity analysis, capture limited data, and often require large sample sizes to be valuable.
Solutions
In-Silico device testing
NumeriCor offers efficient workflows to identify key metrics, such as impedance, DFT, and capture threshold, for new design variants.
This enables a rapid transition between device design and in-silico performance evaluation, elevating the efficiency of the design process to a new level.
Automated workflows allow batch-processing of a large number of design variations.
Ready-to-go digital twins are available
NumeriCor’s proprietary technology covers all stages of cardiac in-silico experiments, from model generation to cardiac simulation and results visualization. NumeriCor’s core products consists in CARP-EP, a cutting-edge simulation engine, Studio, the ultimate end-to-end cardiac simulation graphical interface, and CardioTwin, the cardiac digital twin generation tool. NumeriCor offers various possibilities to collaborate with our team of experts, providing you with the opportunity to work together to improve your technology.